Search

Search Constraints

You searched for: Author/Creator Labrune, Sylvie

Search Results

2. Circulating tumor DNA evaluated by Next-Generation Sequencing is predictive of tumor response and prolonged clinical benefit with nivolumab in advanced non-small cell lung cancer. (4th May 2018)

4. Predictive role of plasmatic biomarkers in advanced non-small cell lung cancer treated by nivolumab. (3rd August 2018)

6. Role of antibiotic use, plasma citrulline and blood microbiome in advanced non-small cell lung cancer patients treated with nivolumab. Issue 1 (10th July 2019)

7. Sequential ctDNA whole-exome sequencing in advanced lung adenocarcinoma with initial durable tumor response on immune checkpoint inhibitor and late progression. Issue 1 (24th June 2020)